-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RgTy23MquEdyGgFX9rH4uzcTNoCLE8EDImgzBGph6ochmR8SniDI2eAq4e8PpfNt BexOpM4mTbwLKwdHXjmi1Q== 0001301800-10-000001.txt : 20101207 0001301800-10-000001.hdr.sgml : 20101207 20101207103329 ACCESSION NUMBER: 0001301800-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20101207 DATE AS OF CHANGE: 20101207 EFFECTIVENESS DATE: 20101207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TyRx Pharma Inc CENTRAL INDEX KEY: 0001301800 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-151474 FILM NUMBER: 101235869 BUSINESS ADDRESS: STREET 1: 1 Deer Park Drive STREET 2: Suite G CITY: Monmouth Junction STATE: NJ ZIP: 08852 BUSINESS PHONE: 732-246-8676 MAIL ADDRESS: STREET 1: 1 Deer Park Drive STREET 2: Suite G CITY: Monmouth Junction STATE: NJ ZIP: 08852 D 1 primary_doc.xml X0704 D LIVE 0001301800 TyRx Pharma Inc 1 Deer Park Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 732-246-8676 DELAWARE Advanced Materials Design, LLC Advanced Materials Design, Inc. None Corporation true Robert S. White 1 Deerpark Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Director Ray Imp 1 Deer Park Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Arthur Pappas 1 Deer Park Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Director Jeffrey Leiden 1 Deer Park Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Director Scott Requadt 1 Deerpark Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Director Michael T. Heffernan 1 Deerpark Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Director William G. Dempsey 1 Deerpark Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Director Edward Cahill 1 Deerpark Drive Suite G Monmouth Junction NJ NEW JERSEY 08852 Director Other Decline to Disclose 06 false 2010-11-23 false true true Certain investors converted their convertible promissory notes to receive Series BB Preferred Stock pursuant to terms of the Series BB Preferred Stock Purchase Agreement. false 0 25169698 23134591 2035107 false 9 0 0 0 false TyRx Pharma Inc /s/ Ray Imp Ray Imp Chief Financial Officer 2010-12-06 -----END PRIVACY-ENHANCED MESSAGE-----